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Abstract: 
 
To investigate the effects of exercise intensity on growth hormone (GH) release, 10 male 
subjects were tested on 6 randomly ordered occasions [1 control condition (C), 5 exercise 
conditions (Ex)]. Serum GH concentrations were measured in samples obtained at 10-min 
intervals between 0700 and 0900 (baseline) and 0900 and 1300 (exercise+ recovery). Integrated 
GH concentrations (IGHC) were calculated by trapezoidal reconstruction. During Ex subjects 
exercised for 30 min (0900–0930) at one of the following intensities [normalized to the lactate 
threshold (LT)]: 25 and 75% of the difference between LT and rest (0.25LT and 0.75LT, 
respectively), at LT, and at 25 and 75% of the difference between LT and peak (1.25LT and 
1.75LT, respectively). No differences were observed among conditions for baseline IGHC. 
Exercise+recovery IGHC (mean ± SE: C = 250 ± 60; 0.25LT = 203 ± 69; 0.75LT = 448 ± 125; 
LT = 452 ± 119; 1.25LT = 512 ± 121; 1.75LT = 713 ± 115 μg ⋅ l−1 ⋅ min−1) increased linearly 
with increasing exercise intensity (P < 0.05). Deconvolution analysis revealed that increasing 
exercise intensity resulted in a linear increase in the mass of GH secreted per pulse and GH 
production rate [production rate increased from 16.5 ± 4.5 (C) to 32.1 ± 5.2 μg ⋅ distribution 
volume−1 ⋅ min−1(1.75LT), P < 0.05], with no changes in GH pulse frequency or half-life of 
elimination. We conclude that the GH secretory response to exercise is related to exercise 
intensity in a linear dose-response pattern in young men. 
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Article: 
 
The growth hormone (GH) response to acute exercise has been studied extensively, with most 
investigators reporting that acute bouts of exercise increase the plasma concentration of GH (4-
6,20). Available studies suggest that intensity and duration of acute exercise, work output during 
exercise, muscle mass used during exercise, fitness, and training state may all influence, in part, 
the GH response to exercise (3-6, 20, 21, 23). Furthermore, the level of aerobic fitness and prior 
training are related to the amount of GH released over a 24-h period (30, 34, 35). 
 
Exercise intensity may play a key role, with exceeding of a particular threshold of exercise 
intensity needed before a significant rise in serum GH concentration occurs (4-6). Although a 
threshold concept has been supposed, no study has examined this proposition systematically. 
Felsing et al. (6) suggested that this exercise intensity threshold may correspond to the lactate 
threshold (LT). Recent indirect data from our laboratory also support the notion that the LT may 
be an important intensity for eliciting a training response (32, 35) and may also be related to GH 
release during exercise (36), possibly through (central) catecholamine release (36). In the present 
study, we examined the effects of exercise intensity on GH secretion in young men. We 
hypothesized that the GH secretory response to exercise would be attenuated until an exercise 
intensity equal to or greater than the LT was reached. 
 
METHODS 
 
Subjects. Ten recreationally active men [mean age = 26 ± 1.1 (SE) yr; mean height, 178 ± 1.7 
cm; mean weight, 83.4 ± 2.8 kg] provided voluntary written informed consent, as approved by 
the Human Investigation Committee of the University of Virginia, before entering the study. 
Each subject underwent a detailed medical history and physical examination, and no subject had 
a history of pituitary, renal, hepatic, or metabolic disease. The subjects were nonsmokers, did not 
abuse alcohol, and were not taking any medication known to affect GH secretion. Screening 
laboratory data revealed normal hematologic, renal, hepatic, metabolic, and thyroid function. 
Subjects refrained from exercise for 24 h before each evaluation. 
 
Experimental design. Each subject completed a treadmill test to assess level of cardiovascular 
fitness and underwent hydrostatic weighing to determine body density (and percent body fat) at 
the Exercise Physiology Laboratory of the General Clinical Research Center (GCRC). Subjects 
were then evaluated on six separate occasions, five with exercise and one at rest; the order of 
study conditions was assigned in a randomized fashion. The admissions were scheduled at least 7 
days apart, and no more than two admissions over a 2-mo period were allowed (to ensure that 
guidelines for blood withdrawal were not exceeded). Exercise consisted of 30 min of constant-
load exercise at a predetermined velocity. Treadmill velocity was set at 25 and 75% of the 
difference between the O2 consumption (V˙o2) at LT andV˙o2 at rest (0.25LT and 0.75LT, 
respectively); at LT (LT); and 25 and 75% of the difference between the V˙o2 at LT and peak 
V˙o2(V˙o2 peak) (1.25LT and 1.75LT, respectively), on the basis of results obtained during a prior 
LT/V˙o2 peak protocol (see below). 
 
Body composition. Body density was assessed by hydrostatic weighing (18). Each subject was 
weighed in air on an Accu-weigh beam scale accurate to 0.1 kg and subsequently weighed 
underwater on a Chatillon autopsy scale accurate to 10 g. Residual lung volume was measured 
by using an O2-dilution technique (40). The computational procedure of Brozek et al. (2) was 
used to determine percent body fat from body density measurements. 
 
LT/V˙o2 peak. A continuous treadmill (Quinton Q 65 treadmill) exercise protocol with increasing 
velocity until volitional fatigue was used to assess LT andV˙o2 peak. The initial velocity was set at 
100 m/min with increases in velocity of 10 m/min every 3 min. Open-circuit spirometry was 
used to collect metabolic data (SensorMedics model 2,900Z metabolic measurement cart, Yorba 
Linda, CA). Heart rate was determined via a Marquette Max-1 electrocardiograph. An 
indwelling venous cannula was inserted into a forearm vein before testing, and blood samples 
were taken at rest and during the last 15 s of each stage for the measurement of blood lactate 
concentration (Yellow Springs Instruments 2700 Select Biochemistry Analyzer, Yellow Springs, 
OH). The test was terminated when the subject reached volitional exhaustion.V˙o2 peak was 
chosen as the highest V˙o2 attained. 
 
Determination of LT. The blood lactate-velocity relationship that was obtained from the 
LT/V˙o2 peak protocol was used to estimate the LT. Velocity at LT was determined by plotting 
blood lactate concentration against treadmill velocity and was chosen as the highest velocity 
obtained before the curvilinear increase in blood lactate concentration with increasing velocities. 
An elevation in blood lactate concentration of at least 0.2 mM (the error associated with the 
lactate analyzer) above baseline was required for LT determination. V˙o2associated with velocity 
LT was then determined (33). 
 
Exercise/control days. Subjects were admitted to the GCRC on the evening before the 
exercise/control studies. Subjects were required to consume their evening meal at or before 1700, 
and then received a standardized snack (500 kcal) at 2000. The nutrient composition of the snack 
was 55% carbohydrate, 15% protein, and 30% fat. Subjects were allowed to consume water ad 
libitum. To avoid the confounding effects of meals on GH secretion, subjects then fasted until 
the end of the study (9, 10). At 2100, an intravenous cannula was placed bilaterally in each 
forearm vein. 
 
Subjects remained at the GCRC after eating their snack and were asked to turn lights off by 2300 
(10, 11). Beginning at 0700, blood samples were withdrawn every 10 min until 1300 for later 
measurement of serum GH concentrations. After 2 h of baseline blood sampling, subjects began 
their exercise bout or remained at rest (C). The exercise bout began at 0900 and continued until 
0930. During the exercise bout, blood lactate was measured every 10 min, and metabolic data 
were measured minute by minute. On completion of exercise, subjects resumed bed rest until 
1300. Subjects were then fed and discharged. 
 
GH analysis. Serum GH concentrations were measured in duplicate by using an ultrasensitive 
chemiluminescence assay (13). The optimized assay consists of 200 μl serum assayed in 
duplicate with 200 μl GH antiserum, overnight shaking incubation, robotic pipetting, and 
automated washing of the antibody-coated polystyrene beads (Nichols Laboratories, San Juan 
Capistrano, CA). All samples from a subject were assayed together to eliminate interassay 
variability. Assay sensitivity defined as 4 SDs above the zero-dose tube was 0.005 μg/l, and that 
defined as 2 SDs above the zero-dose tube was 0.002 μg/l (13). Recombinant human GH (22,000 
Da) was used as the reference standard. No serum GH measurements from these subjects fell 
below 0.005 μg/l at any time, and no more than 5% of all measurements were below 0.015 μg/l. 
The within-assay coefficients of variation ranged from 4.5 to 13%. Within-sample SDs were 
calculated in each subject’s series of 222 samples as dose-dependent values defined by a power 
function relating the within-sample SD to the mean sample GH concentration (for deconvolution 
analysis described below). 
 
Integrated serum GH concentrations (IGHC) were calculated as previously described (26). A 
multiple-parameter deconvolution method was employed to derive quantitative estimates of 
attributes of GH secretory events and monoexponential GH half-life from the measured serum 
GH concentrations (25). In this analysis we used resting, exercise, and postexercise data. The 
inclusion of a long postexercise period was based on the fact that peak GH concentrations are 
typically observed at the end of exercise or within 40-min postexercise and the need to have 
several GH half-lives to apply the analysis. We assumed that individual GH pulses are 
approximated algebraically by a Gaussian distribution of secretory rates (25). Basal secretion 
was estimated for each admission (13, 30). GH secretory pulses were considered significant if 
the fitted amplitude could be distinguished from zero (i.e., pure noise) with 95% statistical 
confidence. The GH secretory pulse half duration (duration at half-maximal amplitude), GH half-
life of elimination, and GH distribution volume were assumed to be constant throughout the 
study period for each individual. The mass of GH secreted per pulse was estimated as the area of 
the calculated secretory pulse [μg/l of distribution volume (μg/lv) × min] (25). The endogenous 
pulsatile GH production rate was estimated as the product of the number of secretory pulses and 
the mean GH mass secreted per pulse. 
 
Statistical analysis. ANOVA with repeated measures was used to determine mean differences 
forV˙o2 and blood lactate concentration. Whenever mean differences were observed, means 
comparisons (corrected for correlated data by using Huynh-Feldt epsilons) were examined. To 
examine the relationship between GH response and exercise intensity, separate regression 
models were estimated for each of the 10 study subjects with the GH response regressed on 
exercise intensity. Separate models were estimated within subjects because of the intraindividual 
correlation that existed between the GH responses across levels of exercise intensity. Such 
methods, while likely to be conservative, were thought to be appropriate because of the limited 
sample size that was available for estimating intraindividual correlation structures. Simple linear 
regression was also used, because in comparison with more complex models that allow for 
curvature, departures from linearity were not apparent. To determine whether a GH response 
changed significantly with exercise intensity, the 10 slopes associated with exercise intensity 
from the individual regression models were then subjected to a Wilcoxon signed-rank test (12). 
Similar methods were used to examine the association between each of the deconvolution 
parameters and exercise intensity. The association between exercise+recovery (0900–1300) 
integrated serum GH concentrations and exercise intensity was further assessed by adding each 
deconvolution parameter to the within-subject regression models. To determine whether the 
relationship between a GH response and exercise intensity was independent of a deconvolution 
parameter, the slopes associated with exercise intensity in the adjusted models were again 
subjected to a Wilcoxon signed-rank test. All data are presented as means ± SE. 
 
RESULTS 
 
Subject characteristics. Subjects’ V˙o2 at LT was 2.72 ± 2.6 l/min (32.6 ± 2.6 ml ⋅ kg−1 ⋅ 
min−1),V˙o2 peak was 3.93 ± 0.19 l/min (47.9 ± 2.2 ml ⋅ kg−1 ⋅ min−1),V˙o2LT/ V˙o2 peak was 0.68 ± 
0.4, and percent body fat was 19.3 ± 1.9%. As expected,V˙o2 at LT andV˙o2 peak were strongly 
correlated with one another (r = 0.79). 
 
V˙o2 and blood lactate concentration during constant-load exercise. One-way ANOVA with 
repeated-measures and post hoc analyses revealed that V˙o2 and blood lactate concentrations 
increased (P < 0.05) across all exercise intensities. The meanV˙o2 at each exercise intensity was 
1.01 ± 0.08 l/min at 0.25LT; 1.85 ± 0.14 l/min at 0.75LT; 2.45 ± 0.18 l/min at LT; 2.98 ± 0.21 
l/min at 1.25LT; and 3.55 ± 0.31 l/min at 1.75LT. TheseV˙o2 values corresponded to 26, 47, 62, 
76, and 90% ofV˙o2 peak, respectively. Thus, whether data were examined relative to LT or 
relative to V˙o2 peak, linear increments in exercise intensity were observed. Mean blood lactate 
values were 0.65 ± 0.05 mM at 0.25LT; 0.93 ± 0.11 mM at 0.75LT; 1.52 ± 0.16 mM at LT; 2.53 
± 0.40 mM at 1.25LT; and 4.94 ± 0.40 mM at 1.75LT (P < 0.05). 
 
GH release. Figure 1 shows the mean serum GH concentrations during blood sampling at 10-
min intervals over 6 h during C, 0.25LT, 0.75LT, LT, 1.25LT, and 1.75LT conditions. No 
differences were observed among conditions for baseline IGHC (0700–0900) (P = 0.20) (data 
not shown). Mean IGHC values during exercise+recovery were as follows: C = 250 ± (SE) 60; 
0.25LT = 203 ± 69; 0.75LT = 448 ± 126; LT = 452 ± 119; 1.25LT = 512 ± 121; 1.75LT = 713 ± 
115 μg ⋅ l−1 ⋅ min−1. The individual relationships between exercise intensity and IGHC during 
exercise+recovery (0900–1300) are shown in Fig. 2. Within-subject regression revealed that 
IGHC increased significantly with each exercise intensity in a linear pattern (P = 0.002). This 
was the case when IGHC was plotted against either %LT (Fig. 2A) or %V˙o2 peak(Fig. 2B). There 
was no suggestion from the data that any of the individual GH responses increased differently 
across the ranges of exercise intensity. For each increase in exercise intensity corresponding to 
0.25LT, exercise+recovery IGHC (4 h) would be expected to increase by ∼70 μg ⋅ l−1 ⋅ min−1. 
 
 
Fig. 1. Mean serum growth hormone (GH) concentrations during blood sampling at 10-min 
intervals over 6 h during control (C); 25 and 75% of difference between O2 uptake (V˙o2) 
achieved at lactate treshold (LT) and V˙o2 at rest (0.25LT and 0.75LT, respectively); and 25 and 
75% of difference between V˙o2 at LT and peakV˙o2 (1.25LT and 1.75LT, respectively) 
conditions. Values are means ± SE;n = 10 subjects. 
 
 
Fig. 2. Relationship between exercise intensity expressed as %LT (top) and %maximal 
V˙o2(V˙o2 max; bottom) and integrated serum GH concentration (μg ⋅ l−1 ⋅ min−1; 
exercise+recovery, 0900–1300). Symbols represent individual concentrations for 10 subjects 
across 6 levels of exercise intensity. Thick solid line is derived from average of intercepts and 
slopes from within-subject regression (thin solid, dashed, and dotted) lines. Integrated serum GH 
increases significantly with exercise intensity (P = 0.002). 
 
For the remaining analyses, we chose to express exercise intensity relative to the LT on the basis 
of the following:1) the strong correlation observed in the present study and reported previously 
between LT andV˙o2 peak(32, 33); 2) data in the literature that suggest that LT may be a marker 
for GH release (6, 35,36); and 3) data that suggest that LT is an important marker of submaximal 
fitness and a strong predictor of endurance performance (32). 
 
Table 1 shows the results of the multiparameter deconvolution analysis of serum GH 
concentrations between 0700 and 1300 as well as the mean slopes and intercepts from the 
regression models. GH production rate, mass of GH secreted per pulse, and GH secretory pulse 
amplitude all increased significantly with increasing exercise intensity (P= 0.014, P = 0.028,P = 
0.004, respectively), whereas GH secretory pulse half duration declined significantly with each 
exercise intensity (P = 0.002). There were no significant associations between exercise intensity 
and any other deconvolution parameter. The regression models indicated that GH production rate 
during the 6-h period would be expected to increase by ∼2.6 μg ⋅ lv−1 ⋅ min−1for each increase in 
exercise intensity corresponding to 0.25LT. This was accounted for by an increase in the mass of 
GH secreted per pulse (0.5 μg/lv for each increase in exercise intensity corresponding to 0.25LT), 
with no change in the number of GH secretory pulses or the GH half-life of elimination. The 
amplitude (maximal rate) of GH secretory pulses increased by ∼0.04 μg ⋅ lv−1 ⋅ min−1with each 
0.25LT increase in exercise intensity, whereas the secretory pulse half duration decreased by 
∼1.1 min with each increase in exercise intensity of 0.25LT. Thus, with increasing exercise 
intensities, GH secretory pulses were of shorter duration but greater amplitude. The positive 
relationship between exercise+ recovery IGHC (0900–1300) and exercise intensity remained 
statistically significant after adjustment for each of the deconvolution parameters, with the 
exception of GH secretory pulse amplitude (P = 0.106), suggesting that increased pulse 
amplitude is the primary statistical determinant of the increase in IGHC with increasing exercise 
intensity. 
 
Table 1. Effects of increasing exercise intensity on specific measures of GH secretion and half-
life during 6 h (0700–1300) as determined by multiple-parameter deconvolution analysis and 
regression analyses 
 
 
Because the GH response to exercise appeared to be completed by 90 min, we examined the 90-
min mean serum GH concentration after the stimulus (0900–1030), the absolute maximal serum 
GH peak response over that same interval, and the summed mass of GH secreted per pulse from 
0900 to 1030 (exercise+1-h recovery). These data are shown in Fig. 3. Statistical analyses 
revealed that 90-min mean serum GH (A), peak GH (B), and the summed mass of GH secreted 
per pulse (C) increased significantly with exercise intensity (P = 0.004,P = 0.002, and P = 0.006, 
respectively). For each added increase in exercise intensity in the amount of 0.25LT, 90-min 
mean serum GH would be expected to increase an average of 0.73 μg/l, peak GH would be 
expected to increase an average of 1.7 μg/l, and the summed GH mass secreted per pulse would 
be expected to increase an average of 3.1 μg/lv over the 90 min. 
 
 
Fig. 3. Mean serum GH concentration (top), absolute maximal serum GH peak response 
(middle), and summed GH mass secreted per pulse (bottom) over a 90-min interval (exercise+1-h 
recovery, 0900–1030h) according to exercise intensity. Thick solid line is derived from average 
of intercepts and slopes from within-subject regression (thin solid, dashed, and dotted) lines. 
Mean serum GH at 90 min, peak GH, and summed mass secreted per pulse increase significantly 
with exercise intensity (P = 0.004,P = 0.002, and P = 0.006, respectively). 
 
DISCUSSION 
 
Although an acute bout of exercise of appropriate intensity will evoke a large increase in serum 
GH concentrations (3-6, 17, 23, 36), little quantitative information is available regarding the 
precise relationship between specific levels of exercise intensity and the magnitude of the GH 
response. We had postulated a threshold relationship between intensity of exercise and the GH 
secretory response to exercise and that the GH response to exercise would be relatively 
attenuated until an exercise intensity equal to or greater than the LT was reached. Accordingly, 
five exercise intensities were chosen in the present study so that the relationship between 
exercise intensity and GH release could be evaluated systematically. 
 
The major findings of the present study support the hypothesis that the GH secretory response to 
exercise is related positively to exercise intensity. The GH secretory response to exercise rose 
with increasing exercise intensities below or equal to LT and was followed by a continuing 
increase in IGHC above LT (Fig. 2). Notably, exercise intensities below the LT resulted in a 
stimulation of GH release. Thus, in contrast to our stated hypothesis of a threshold relationship 
between exercise intensity and the GH response (i.e., no rise or a gradual increase in GH release 
at intensities below LT and a much greater increase in GH release at intensities above LT), it 
appears that a linear dose-response relationship exists between exercise intensity and the GH 
secretory response. 
 
Multiple-parameter deconvolution analysis was employed to examine whether the increase in 
IGHC with increasing exercise intensities was due to increased GH secretion, decreased 
clearance of GH, or both. The major assumptions of deconvolution analysis have been well 
established in the published literature both technically and experimentally (27). In particular, the 
two principal assumptions are, first, that the half-life is subject specific and invariant across a 
sampling session, which we have been able to document in test-retest studies (7). The second 
assumption is that GH is secreted in bursts, which has now been demonstrated in humans by 
direct catheretization of the inferior petrosal sinus (24). Other indirect data also indicate burstlike 
secretion on the basis of high-frequency of blood sampling at 30-s intervals overnight (11). 
 
The present analysis indicated that exercise-enhanced IGHC was mechanistically attributable to 
a linear increase in the mass of GH secreted per pulse with increasing exercise intensity. The 
latter reflected a linear increase in secretory pulse amplitude and occurred despite a small but 
linear decrease in secretory pulse half duration [Table 1; the mass per pulse is controlled jointly 
and linearly by pulse amplitude and duration (29)]. There was no major effect of exercise 
intensity on the number of secretory GH episodes or the calculated GH half-life during the 6-h 
sampling period. These findings are consistent with our previous report of the effect of repeated 
exercise bouts on attributes of GH secretory pulses (17). 
 
Exercise elicited an apparent alteration in the pulse width of GH secretion with GH secretory 
pulses of shorter duration, but greater amplitude. In principle, this GH secretory pattern change is 
consistent with concurrent amplification of GHRH (and/or cosecretagogue) release and more 
rapid-onset reciprocal somatostatin inhibition during intense exercise (8). Reciprocal 
intrahypothalamic connections between GHRH and somatostatin-secreting neurons (39) will 
allow for possible rapid stimulation of somatostatin release by GHRH neuronal activation, as has 
been inferred, for example, in vitro in bovine brain explant experiments (38). Thus exercise may 
activate GHRH and, secondarily, somatostatin secretion, with the latter appropriately timed to 
maximize the mass of GH released per pulse. Indeed, pulsed GHRH infusions in young men also 
remarkably abbreviated the duration of evoked GH secretory bursts (14). Modeling experiments 
also indicate the mechanistic feasibility of this hypothesis from a feedback network perspective 
(22). 
 
Although it is possible that exercise may induce changes in GH-binding protein, to our 
knowledge there are no evident changes in GH-binding protein concentrations associated with 
exercise. The GH-binding proteins are thought to represent the extracellular domain of the GH 
receptor and are high-affinity binding proteins. There is no particular reason why their 
intravascular distribution should be greatly changed in the course of exercise. In addition, any 
major alteration in the binding protein level would be predicted on mathematical grounds to alter 
the GH half-life, as reported earlier in modeling studies (28). In fact, we do not observe this (see 
Table 1). 
 
Although the present data suggest that a relationship exists between exercise intensity 
normalized against the LT and GH release, we cannot suggest a causal relationship. Because 
infusions of lactate do not stimulate GH release (21), it is unlikely that circulating lactate itself is 
responsible for the GH response to exercise. The LT may be a marker for other physiological 
events, e.g., intramuscular acidosis, mechano- or chemoreceptor activation, or relative muscle 
ischemia, and so on (31), which are more closely related to the stimulation of GH secretion 
during exercise. For example, changes in blood lactate and catecholamine release follow similar 
patterns in response to exercise (37). We hypothesize that the GH response to exercise is more 
strongly related to the central nervous system drive underlying the evident catecholamine 
responses. Indeed, sympathetic activity may be an important mediator of the GH response to 
acute exercise (5, 10, 23, 36), with greater sympathetic activity (reflected peripherally by 
epinephrine and norepinephrine release) associated with greater GH responses to exercise 
(19, 20). Presently, the precise relationship between peripheral plasma catecholamine 
concentrations and the activity of central adrenergic neurons (presumptively, α2) that regulate 
GH secretion is unknown, although the blood GH and catecholamine responses to exercise 
training are parallel (36). Because the sympathetic (catecholaminergic) and parasympathetic 
(cholinergic) autonomic pathways (8) may, in part, regulate GH release during exercise, studies 
to systematically investigate the direct relationship between intensity of exercise and the central 
neuronal adrenergic outflow are warranted. 
 
Although the present data may have implications for exercise prescription, it is unknown whether 
the greater stimulation of GH secretion with increasing exercise intensity will lead to greater 
clinical benefits. Administration of human GH to GH-deficient adults and abdominally obese 
men has been reported to reduce abdominal/visceral obesity, improve insulin sensitivity, affect 
lipoprotein and bone metabolism favorably, lower diastolic blood pressure, and increase 
muscular strength (1, 15, 16). Because exercise intensity appears to be linearly related to 
increases in endogenous GH secretion, we hypothesize that higher training intensities will have 
greater clinical utility than lower training intensities. This is based on the use of a 30-min 
exercise prescription. However, it is possible that longer-duration exercise at lower intensity may 
also be of clinical benefit. In addition, this conjecture should be tempered by the qualification 
that the effects of exercise intensity on GH release in women, GH-deficient, and older and/or 
obese subjects may not be comparable to the present observations in young healthy men. 
 
In summary, the present study indicates that, in young men, the magnitude of GH release rises 
linearly with increasing exercise intensity, with an apparent dose-response relationship observed 
between exercise intensity normalized against the LT and GH release. This augmentation of GH 
production rates with increasing intensity of exercise is attributable mechanistically to an 
increase in the mass of GH secreted per pulse. This appears to be a highly specific 
neuroendocrine response, as the number of GH secretory pulses and the GH half-life are not 
affected by exercise intensity. 
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